(NEW YORK)Obesity drug developers may have trouble getting drugs reimbursed by private and government health plans, though physicians will likely be enthusiastic about the treatments, said L...READ MORE
Among the earnings stories for Friday, Aug. 8, from AP Financial News: NEW YORK (AP)_ Shares of Dionex Corp. fell sharply Friday after the laboratory equipment maker reported bette...READ MORE
(SAN DIEGO)Obesity drug developer Orexigen Therapeutics Inc. said its second-quarter loss nearly doubled from last year as it continued testing its drug candidates.READ MORE
(SAN DIEGO)Obesity drug developer Orexigen Therapeutics Inc. said Tuesday the U.S. Patent and Trademark Office issued a patent covering its lead candidate. The drug candidate, Contrave, is in...READ MORE